Can the Interim Fluorodeoxyglucose–Positron Emission Tomography Standardized Uptake Value Be Used to Determine the Need for Residual Mass Biopsy After Dose-Dense Immunochemotherapy for Advanced Diffuse Large B-Cell Lymphoma?-Reference-Cited by-同舟云学术

Can the Interim Fluorodeoxyglucose–Positron Emission Tomography Standardized Uptake Value Be Used to Determine the Need for Residual Mass Biopsy After Dose-Dense Immunochemotherapy for Advanced Diffuse Large B-Cell Lymphoma?

Published:2010-12-01 Issue:34 Volume:28 Page:e719-e720
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Juweid Malik E.¹,Smith Brian²,Itti Emmanuel³,Meignan Michel³

Affiliation:

1. Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA

2. Department of Public Health, Iowa City, IA

3. Henri Mondor Hospital, Assistance Publique—Hôpitaux de Paris/Université Paris-Est, Créteil, France

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.30.4394

Reference7 articles.

1. Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma

2. Interim18F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation – where do we stand?

3. Prognostic Value of Interim 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment at 4 Cycles of Chemotherapy

4. Role of Positron Emission Tomography in Lymphoma

5. Positron-Emission Tomography and Assessment of Cancer Therapy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Core Needle Biopsy Targeting the Viable Area of Deep-Sited Dominant Lesion Verified by Color Doppler and/or Contrast-Enhanced Ultrasound Contribute to the Actionable Diagnosis of the Patients Suspicious of Lymphoma;Frontiers in Oncology;2020-10-07

2. PET Molecular Imaging–Directed Biopsy: A Review;American Journal of Roentgenology;2017-08

3. Interim PET-driven strategy in de novo diffuse large B-cell lymphoma: do we trust the driver?;Blood;2017-06-08

4. Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphoma;Leukemia & Lymphoma;2013-09-16

5. An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax;European Journal of Nuclear Medicine and Molecular Imaging;2013-05-07